(2006). Arachidonic acid cascade and epithelial barrier function during Caco-2 cell differentiation.
(2008). Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology.
(1991). Caco-2 cells cultured in serum-free medium as a model for the study of enterocytic differentiation in vitro.
(2005). Cell death induced by the herpes simplex virus-1 thymidine kinase delivered by human immunodeficiency virus-1-based virus-like particles.
(1998). Characterization of furazolidone apical relative effect to human polarized intestinal cell line.
(2000). cis expression of the F12 human immunodeficiency virus (HIV) Nef allele transforms the highly productive NL4-3 HIV type 1 to a replication-defective strain: involvement of both Env gp41 and CD4 intracytoplasmic tails.
(2003). Critical role for Nef in HIV-1-induced podocyte dedifferentiation.
(2008). Cytokineinduced epithelial permeability changes are regulated by the activation of the p38 mitogen-activated protein kinase pathway in cultured Caco-2 cells.
(1997). Direct effect of type 1 human immunodeficiency virus (HIV-1) on intestinal epithelial cell differentiation: relationship to HIV-1 enteropathy.
(2011). Effects of HIV-1 Nef on virus co-receptor expression and cytokine release in human bladder, laryngeal, and intestinal epithelial cell lines.
(2003). Effects of HIV-1 Tat protein on ion secretion and on cell proliferation in human intestinal epithelial cells.
(2001). Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management.
(2009). Epstein-Barr virus LF2: an antagonist to type I interferon.
(2005). Evolution of nef variants in gut associated lymphoid tissue of rhesus macaques during primary simian immunodeficiency virus infection.
(1996). Gastrointestinal manifestations of HIV infection.
(2005). HIV infection and the gastrointestinal tract.
(1998). HIV-1 gp120 accelerates Fas-mediated activation-induced human lamina propria T cell apoptosis.
(2003). HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication.
(2008). HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein.
(2004). HIV-1 Nef equips dendritic cells to reduce survival and function of CD8+ T cells: a mechanism of immune evasion.
(2007). HIV-1 Nef impairs the dynamic of DC/NK crosstalk: different outcome of CD56(dim) and CD56(bright) NK cell subsets.
(2005). HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN.
(2002). HIV-1 Nef induces dendritic cell differentiation: a possible mechanism of uninfected CD4(+) T cell activation.
(1999). HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages.
(2000). HIV-1 Nef protein inhibits the in vitro induction of a specific antibody response to Candida albicans by an early up-regulation of IL-15 production.
(2008). HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions.
(2002). HIV1 Nef induces proliferation and anchorage-independent growth in podocytes.
(2003). HIV1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells.
(2005). Hosmalin A
(2003). Human immunodeficiency virus type 1 (HIV-1) Nef activates STAT3 in primary human monocyte/macrophages through the release of soluble factors: involvement of Nef domains interacting with the cell endocytotic machinery.
(2006). Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse.
(2009). Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells.
(2004). Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines.
(1990). Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression.
(2009). Immunoregulatory effects of HIV-1 Nef protein.
(1999). Induction of interleukin-15 production by HIV-1 nef protein: a role in the proliferation of uninfected cells.
(2006). Inhibitory effect of HIV-1 Tat protein on the sodium-D-glucose symporter of human intestinal epithelial cells.
(1992). Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells.
(1989). Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers.
(1995). Interferongamma inhibits HIV-induced invasiveness of monocytes.
(1999). Interferongamma upregulates CCR5 expression in cord and adult blood mononuclear phagocytes.
(2009). Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells.
(2006). Microbial translocation is a cause of systemic immune activation in chronic HIV infection.
(2008). Mucosal immunedysfunction in AIDS pathogenesis.
(2001). Nef from human immunodeficiency virus type 1(F12) inhibits viral production and infectivity.
(2003). Proinflammatory cytokines disrupt epithelial barrier function by apoptosisindependent mechanisms.
(2006). Role of epithelial cells in initiation and propagation of intestinal inflammation. Eliminating the static: tight junction dynamics exposed.
(2008). Role of Nef in primate lentiviral immunopathogenesis.
(2000). T-tropic human immunodeficiency virus (HIV) type 1 Nef protein enters human monocyte-macrophages and induces resistance to HIV replication: a possible mechanism of HIV T-tropic emergence in AIDS.
(1992). The effect of cytokines and pharmacologic agents on chronic HIV infection.
(2000). Treatmentinduced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection.